Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Catalepsy

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    6 result(s) found for: Catalepsy. Displaying page 1 of 1.
    EudraCT Number: 2007-000800-34 Sponsor Protocol Number: H8Y-MC-HBBI Start Date*: 2007-08-14
    Sponsor Name:Eli Lilly and Company Ltd.
    Full Title: A Multi-center, Inpatient, Phase 2, Double-blind, Placebo-controlled Dose Ranging Study of LY2140023 in Patients with DSM-IV Schizophrenia.
    Medical condition: Patients must have a diagnosis of Schizophrenia as defined in Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (Disorganized, 295.10; Catatonic, 295.20; Paranoid, 295....
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039638 Schizophrenia, disorganised type PT
    9.1 10039637 Schizophrenia, catatonic type PT
    9.1 10039639 Schizophrenia, paranoid type PT
    9.1 10039640 Schizophrenia, residual type PT
    9.1 10052792 Schizophrenia, undifferentiated type PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) PT (Completed) AT (Completed)
    Trial results: View results
    EudraCT Number: 2008-000479-11 Sponsor Protocol Number: 12396A Start Date*: 2008-07-21
    Sponsor Name:H. Lundbeck A/S
    Full Title: A randomised, double-blind, parallel-group, active-controlled, flexible dose study exploring the efficacy and safety of 12 weeks treatment with Lu 31-130 in patients with schizophrenia
    Medical condition: Lu 31-130 is under development by H. Lundbeck A/S as an antipsychotic in the treatment of schizophrenia
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039639 Schizophrenia, paranoid type PT
    9.1 10039637 Schizophrenia, catatonic type PT
    9.1 10039638 Schizophrenia, disorganised type PT
    9.1 10052792 Schizophrenia, undifferentiated type PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: CZ (Completed) FR (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2010-022181-28 Sponsor Protocol Number: 13639A Start Date*: 2011-02-07
    Sponsor Name:H. Lundbeck A/S
    Full Title: A 6-month, randomised, double-blind, parallel-group, risperidone-controlled, fixed-dose study evaluating the safety and efficacy of zicronapine in patients with schizophrenia
    Medical condition: Schizophrenia
    Disease: Version SOC Term Classification Code Term Level
    14.0 10037175 - Psychiatric disorders 10039638 Schizophrenia, disorganised type PT
    14.0 10037175 - Psychiatric disorders 10039639 Schizophrenia, paranoid type PT
    14.0 10037175 - Psychiatric disorders 10052792 Schizophrenia, undifferentiated type PT
    14.0 10037175 - Psychiatric disorders 10039637 Schizophrenia, catatonic type PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Completed) EE (Completed) CZ (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2009-009215-22 Sponsor Protocol Number: BISCLOZ Start Date*: 2009-03-26
    Sponsor Name:Aalborg Psychiatric Hospital, Centre for Skizophrenia
    Full Title: “Treating clozapine-induced sinustachycardia (BISCLOZ).”
    Medical condition: Clozapine induced sinuatachycardia treated with bisoprolol.
    Disease: Version SOC Term Classification Code Term Level
    15.1 100000004873 10013387 Disorganized type schizophrenia LLT
    15.1 100000004873 10013386 Disorganised schizophrenia LLT
    15.1 100000004873 10019364 Hebephrenic schizophrenia LLT
    15.1 100000004873 10007780 Catatonic schizophrenia LLT
    15.1 100000004873 10033872 Paranoid schizophrenia LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2010-024488-42 Sponsor Protocol Number: 2010-024488-42-PACS Start Date*: 2011-01-31
    Sponsor Name:Aalborg University Hospital, Aalborg Psychiatric Hospital, Centre for Psychosisresearch
    Full Title: Pregabalin for anxiety comorbidity in patients with schizophrenia (PACS) - A Double-blinded Randomized Placebo Controlled Trial
    Medical condition: anxiety-comorbidity to schizophrenia
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004873 10013387 Disorganized type schizophrenia LLT
    19.0 100000004873 10013386 Disorganised schizophrenia LLT
    19.0 100000004873 10007780 Catatonic schizophrenia LLT
    19.0 100000004873 10019364 Hebephrenic schizophrenia LLT
    19.0 100000004873 10033872 Paranoid schizophrenia LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2008-008366-13 Sponsor Protocol Number: 3.0edition Start Date*: 2009-03-17
    Sponsor Name:Unit for Psychiatric Research
    Full Title: Comparison of the effects of Sertindole and Olanzapine on Cognition
    Medical condition: Cognitive deficits in patients with schizophrenia
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019364 Hebephrenic schizophrenia LLT
    9.1 10046150 Unspecified schizophrenia LLT
    9.1 10052792 Schizophrenia, undifferentiated type LLT
    9.1 10007780 Catatonic schizophrenia LLT
    9.1 10033877 Paranoid type schizophrenia LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Prematurely Ended) SE (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 16 16:14:51 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA